Stay updated on Trastuzumab Emtansine in HER2+ Tumors Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    A new site revision tag v3.5.4 was added and the previous tag v3.5.3 was removed, indicating a small software update to the page rendering.
    Difference
    0.0%
    Check dated 2026-05-15T16:04:50.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page revision/version string was updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the clinical study record details.
    Difference
    0.0%
    Check dated 2026-04-24T06:29:11.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 from the revision history.
    Difference
    0.0%
    Check dated 2026-04-17T02:47:37.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    Location name updated from Padua to Padova for the Veneto, Italy site (35128).
    Difference
    0.0%
    Check dated 2026-04-09T21:43:51.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0 with the v3.4.3 label removed.
    Difference
    0.0%
    Check dated 2026-03-19T06:26:01.000Z thumbnail image
  9. Check
    76 days ago
    Change Detected
    Summary
    Revision labels updated: v3.4.3 added and v3.4.2 removed.
    Difference
    0.0%
    Check dated 2026-03-12T02:32:37.000Z thumbnail image

Stay in the know with updates to Trastuzumab Emtansine in HER2+ Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page.